These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 2860942)
41. Pharmacological and biochemical actions of sulphasalazine. Hoult JR Drugs; 1986; 32 Suppl 1():18-26. PubMed ID: 2877850 [TBL] [Abstract][Full Text] [Related]
42. Sulphasalazine in the treatment of rheumatoid arthritis. Pelísková Z; Vácha J; Trnavský K Z Rheumatol; 1985; 44(6):263-6. PubMed ID: 2869625 [TBL] [Abstract][Full Text] [Related]
43. A rapid method for the simultaneous determination of the major metabolites of sulphasalazine in plasma. Shaw PN; Sivner AL; Aarons L; Houston JB J Chromatogr; 1983 May; 274():393-7. PubMed ID: 6135701 [No Abstract] [Full Text] [Related]
45. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis. Porter D; Madhok R; Hunter JA; Capell HA Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of leucocyte motility by drugs used in ulcerative colitis. Rhodes JM; Bartholomew TC; Jewell DP Gut; 1981 Aug; 22(8):642-7. PubMed ID: 6116649 [TBL] [Abstract][Full Text] [Related]
47. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization? Madhok R; Wijelath E; Smith J; Watson J; Sturrock RD; Capell HA J Rheumatol; 1991 Feb; 18(2):199-202. PubMed ID: 1708829 [TBL] [Abstract][Full Text] [Related]
48. An experiment to determine the active therapeutic moiety of sulphasalazine. Azad Khan AK; Piris J; Truelove SC Lancet; 1977 Oct; 2(8044):892-5. PubMed ID: 72239 [TBL] [Abstract][Full Text] [Related]
49. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis? Nakshabendi IM; Duncan A; Russell RI Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343 [TBL] [Abstract][Full Text] [Related]
50. Clinical pharmacokinetics of sulphasalazine. Das KM; Dubin R Clin Pharmacokinet; 1976; 1(6):406-25. PubMed ID: 15752 [TBL] [Abstract][Full Text] [Related]
51. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine. Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150 [TBL] [Abstract][Full Text] [Related]
52. Adverse effects with oral 5-aminosalicyclic acid. Fardy JM; Lloyd DA; Reynolds RP J Clin Gastroenterol; 1988 Dec; 10(6):635-7. PubMed ID: 2906645 [TBL] [Abstract][Full Text] [Related]
53. In vitro immunomodulatory effects of sulfasalazine and its metabolites. Comer SS; Jasin HE J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646 [TBL] [Abstract][Full Text] [Related]
54. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate. Bax DE; Amos RS Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182 [TBL] [Abstract][Full Text] [Related]
55. Sulphasalazine in ulcerative colitis. Michalowski AS Gut; 1992 Nov; 33(11):1582. PubMed ID: 1360440 [No Abstract] [Full Text] [Related]
56. Sulphasalazine in arthritis--an old drug rediscovered. Taggart AJ Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913 [TBL] [Abstract][Full Text] [Related]
57. Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: a randomised double blind trial. Faarvang KL; Egsmose C; Kryger P; Pødenphant J; Ingeman-Nielsen M; Hansen TM Ann Rheum Dis; 1993 Oct; 52(10):711-5. PubMed ID: 7903034 [TBL] [Abstract][Full Text] [Related]
58. Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action? Sheldon P; Webb C; Grindulis KA Br J Rheumatol; 1988 Oct; 27(5):344-9. PubMed ID: 2902897 [TBL] [Abstract][Full Text] [Related]
59. Sulphasalazine-induced leucopenia in a patient with renal dysfunction. Teshima D; Hino B; Makino K; Yano T; Itoh Y; Joh Y; Iida M; Oishi R J Clin Pharm Ther; 2003 Jun; 28(3):239-42. PubMed ID: 12795783 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of red cell membrane lipid peroxidation by sulphasalazine and 5-aminosalicylic acid. Greenfield SM; Punchard NA; Thompson RP Gut; 1991 Oct; 32(10):1156-9. PubMed ID: 1683330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]